Drug intelligence / Profile preview

4-[18F]Fluoroglutamic acid

Development stage
Phase 1
Lead developer
Bayer
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

**4-[18F]Fluoroglutamic acid (BAY85-8050)** is a radiolabeled amino acid derivative developed as a positron emission tomography (PET) imaging agent. It consists of fluorine-18 conjugated to L-glutamic acid, which leverages tumor-specific uptake due to high glutaminolytic metabolism in certain tumors. Upon intravenous administration, it accumulates in tumor cells, enabling imaging and assessment using PET. The compound is intended for oncology imaging, specifically for detecting and assessing neoplasms via PET scans. The developer is Bayer.

Other names
2-amino-4-(18F)-fluoropentanedioic acid4-fluoroglutamic acidgamma-fluoroglutamic acid4-fluoroglutamic acid (L)-isomerL-glutamic acid 4-(fluoro-18F)-
02

Targets

EAAT3 (Excitatory amino acid transporter 3)SLC7A11 (Cystine-Glutamate Antiporter)

Beyond the preview

Go deeper on 4-[18F]Fluoroglutamic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-[18F]Fluoroglutamic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call